Form 4: DENTSPLY SIRONA Director Gregory Lucier Reports Acquisition of Over 20,000 Shares Through RSU Grant
Insider Transaction Report
DENTSPLY SIRONA Inc. Director Gregory T. Lucier reported the acquisition of 20,189 shares of common stock through a Restricted Stock Unit grant on May 22, 2025, increasing his direct beneficial ownership.
Summary
- Gregory T. Lucier, a Director of DENTSPLY SIRONA Inc. (XRAY), acquired 20,189 shares of common stock.
- The acquisition occurred on May 22, 2025, and was a grant of Restricted Stock Units (RSUs).
- The RSUs were acquired at a price of $0 per share, which is typical for equity grants.
- These RSUs are scheduled to vest in full (restrictions lapse) one year from the date of grant.
- Following this transaction, Mr. Lucier directly beneficially owns 102,287.657 shares of common stock.
- Additionally, Mr. Lucier indirectly beneficially owns 21,000 shares through his Gregory Lucier IRA.
Sentiment
Score: 7
Explanation: The acquisition of shares by a director, even through an RSU grant, generally indicates alignment of interests with shareholders and confidence in the company's future. This is a positive signal, though not as strong as an open market purchase.
Positives
- The acquisition of 20,189 shares by a director, even through an RSU grant, aligns management's interests with those of shareholders, indicating confidence in the company's future performance.
- The grant of Restricted Stock Units is a common form of equity compensation, incentivizing long-term commitment and performance from key personnel.
Future Outlook
The acquired Restricted Stock Units are set to vest in full one year from the grant date, indicating a future increase in the director's vested shareholdings.
Industry Context
This Form 4 filing is a routine disclosure of an insider equity transaction, common across all industries for publicly traded companies. It reflects standard compensation practices for directors, aligning their financial interests with the company's long-term performance.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Policy | The grant of Restricted Stock Units to a director is part of the company's established equity compensation plan, designed to incentivize long-term performance and align director interests with shareholders. | 05/22/2025 | Strengthens alignment between director and shareholder interests, potentially improving long-term governance and strategic decision-making. |
Related Party Transactions
- The grant of 20,189 Restricted Stock Units to Gregory T. Lucier, a Director, constitutes a related party transaction as it involves compensation from the company to an insider.
Stakeholder Impact
- Shareholders: The RSU grant aligns the director's financial interests with the company's performance, potentially leading to more shareholder-friendly decisions and long-term value creation.
- Management/Employees: This transaction reflects the company's compensation strategy, which can influence morale and retention of key personnel.
Next Steps
- The 20,189 Restricted Stock Units are expected to vest in full one year from the grant date of May 22, 2025.
Key Dates
| Date | Description |
|---|---|
| 05/22/2025 | Date of transaction: Acquisition of 20,189 Restricted Stock Units (RSUs) by Gregory T. Lucier. |
| 05/22/2026 | Estimated vesting date for the 20,189 Restricted Stock Units (one year from grant date). |
| 05/27/2025 | Date the Form 4 was signed by the Attorney-in-Fact for Gregory T. Lucier. |
Keywords
DENTSPLY SIRONA, XRAY, Form 4, Insider Transaction, Restricted Stock Units, RSU, Equity Grant, Beneficial Ownership, Director Compensation, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.